Bruce Stroever
CIK: 0001657728
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBLG
Bone Biologics Corp
Director
Discretionary Trading P&L
Holdings
About Stroever Bruce
Stroever Bruce (SEC CIK 0001657728) files insider reports with the SEC as Director of Bone Biologics Corp (BBLG).
Signal8 holds 2 ownership filings by Stroever Bruce, all Form 4s, filed between Sep 19, 2024 and Jun 6, 2025. Those filings report 2 transactions, from Sep 17, 2024 to Jun 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Stroever Bruce's filings is in BURLINGTON,, MA.
Recent filings by Stroever Bruce
Other insiders filing for Bone Biologics Corp (BBLG)
- Walsh Deina H, Chief Financial Officer
- Frelick Jeff, Chief Executive Officer
- Meikle Phillip Terry II, Director
- Angle Siddhesh Rajendra, Director
- Gagnon Robert E., Director